HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dajun Yang Selected Research

Sirtuin 1

5/2010Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dajun Yang Research Topics

Disease

36Neoplasms (Cancer)
12/2023 - 04/2003
6Nasopharyngeal Carcinoma
01/2018 - 11/2008
6Breast Neoplasms (Breast Cancer)
08/2009 - 10/2002
5Stomach Neoplasms (Stomach Cancer)
11/2023 - 11/2014
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2023 - 01/2019
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 06/2008
4Lymphoma (Lymphomas)
12/2009 - 02/2008
3Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 12/2022
3Multiple Myeloma
12/2022 - 06/2008
3Leukemia
01/2022 - 07/2007
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2011 - 06/2008
3Pancreatic Neoplasms (Pancreatic Cancer)
05/2010 - 04/2010
3Prostatic Neoplasms (Prostate Cancer)
01/2007 - 05/2004
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023 - 12/2022
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 01/2022
2Neoplasm Metastasis (Metastasis)
06/2017 - 09/2013
2Carcinogenesis
01/2015 - 05/2012
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2009 - 02/2008
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2023
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2023
1Tumor Lysis Syndrome
01/2023
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
12/2022
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2019
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
01/2018
1Hepatocellular Carcinoma (Hepatoma)
01/2018
1B-Cell Leukemia (Leukemia, B Cell)
08/2017
1Papillary Thyroid Cancer
06/2017
1Colonic Neoplasms (Colon Cancer)
01/2015
1Colorectal Neoplasms (Colorectal Cancer)
01/2011
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
04/2010
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2008

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2023 - 10/2002
6GossypolIBA
08/2013 - 07/2003
5LisaftoclaxIBA
12/2023 - 01/2022
5olverembatinibIBA
01/2023 - 01/2019
5Tyrosine Kinase InhibitorsIBA
01/2023 - 01/2022
5apogossypoloneIBA
09/2014 - 02/2008
4Phosphotransferases (Kinase)IBA
01/2019 - 02/2006
3CaspasesIBA
11/2023 - 01/2018
3Inhibitor of Apoptosis ProteinsIBA
01/2018 - 04/2011
3LigandsIBA
01/2015 - 04/2003
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2012 - 10/2002
3GemcitabineFDA Link
10/2011 - 04/2010
3MI 319IBA
05/2010 - 12/2009
2ParaffinIBA
10/2022 - 01/2015
2APG-1387IBA
01/2018 - 10/2016
2DNA (Deoxyribonucleic Acid)IBA
08/2013 - 04/2010
2Cisplatin (Platino)FDA LinkGeneric
04/2010 - 11/2008
2MI-219IBA
12/2009 - 03/2008
29-chloro-2-methylellipticinium acetateIBA
07/2007 - 01/2007
2PeptidomimeticsIBA
10/2003 - 07/2003
2Peptides (Polypeptides)IBA
08/2003 - 07/2003
1pelcitoclaxIBA
11/2023
1Transcription Factors (Transcription Factor)IBA
10/2023
1MicroRNAs (MicroRNA)IBA
10/2023
1Coatomer Protein (Archain)IBA
10/2023
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
01/2023
1venetoclaxIBA
01/2023
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2022
1ErbB Receptors (EGF Receptor)IBA
07/2022
1Drug CombinationsIBA
07/2022
1Paclitaxel (Taxol)FDA LinkGeneric
07/2022
1Carboplatin (JM8)FDA LinkGeneric
07/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2022
1Aldehyde DehydrogenaseIBA
07/2022
1MitogensIBA
07/2022
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2022
1trametinibIBA
07/2022
1osimertinibIBA
07/2022
1Tetrazolium SaltsIBA
07/2022
1STAT5 Transcription FactorIBA
01/2022
1Anaplastic Lymphoma KinaseIBA
11/2020
1pembrolizumabIBA
11/2019
1Immune Checkpoint InhibitorsIBA
11/2019
1Imatinib Mesylate (Gleevec)FDA Link
01/2019
1ponatinibIBA
01/2019
1Messenger RNA (mRNA)IBA
01/2018
1IodineIBA
06/2017
1Wnt ProteinsIBA
01/2015
1human ERBB2 proteinIBA
11/2014
1Antineoplastic Agents (Antineoplastics)IBA
08/2013
1Acetates (Acetic Acid Esters)FDA Link
08/2013
1houttuyninumIBA
05/2012
1ErbB-2 ReceptorIBA
05/2012
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
10/2011
1N- benzhydryl- 5- (2- (methylamino)propanamido)- 3- (3- methylbutanoyl)- 6- oxodecahydropyrrolo(1,2- a)(1,5)diazocine- 8- carboxamideIBA
04/2011
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2011
1Sirtuin 1IBA
05/2010
1EnzymesIBA
04/2010
1Histones (Histone)IBA
04/2010
1ImmunosorbentsIBA
04/2010
1nutlin 3IBA
12/2009
1Proteasome Endopeptidase Complex (Proteasome)IBA
09/2008
1Proteasome InhibitorsIBA
09/2008

Therapy/Procedure

16Therapeutics
07/2022 - 06/2003
4Radiotherapy
09/2013 - 10/2003
3Immunotherapy
12/2023 - 01/2015
2Oral Administration
11/2020 - 05/2010
1Drug Therapy (Chemotherapy)
09/2013
1Aftercare (After-Treatment)
08/2013